Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies

Meader, Nick; Mitchell, Alex J.; Chew‐Graham, Carolyn; Goldberg, David; Rizzo, Maria Rosaria; Bird, Victoria; Keßler, David; Packham, Jon; Haddad, Mark; Pilling, Stephen

doi:10.3399/bjgp11x613151

Cited by 111 publications

(107 citation statements)

References 159 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In each case, the results obtained with HADS-D were significantly lower than the results from the use of other scales, suggesting that HADS is not an effective and satisfactory tool for assessing CAD patients with comorbid depression. Also, research conducted by Meader et al [18] identified the diagnostic superiority of PHQ-9 over HADS-D among patients with medical comorbidities. Similar conclusions were drawn by Haddad et al [19], who compared diagnostic values of these tools in patients with CAD.…”

Section: Phq-15mentioning

confidence: 99%

Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument

et al. 2016

View full text Add to dashboard Cite

A b s t r a c t Background:The presence of depression symptomatology significantly deteriorates the prognosis for the patient. There are many instruments developed to measure depression and anxiety in clinical trials; however, the suitability of the specific scale for screening these disorders in cardiovascular patients is debatable. The aim of current study is to verify which of the major assessment instruments is the most relevant for the screening evaluation of depression and anxiety in patients with cardiovascular system diseases. Aim:The sample studied consisted of 120 patients with stable coronary artery disease (CAD). They did not display serious psychiatric or somatic disorders. Methods:To assess depressive and anxiety symptoms we used self-reporting measures (BDI-II, HADS, SSAI/STAI, and PHQ), the results of which were compared to results obtained on the basis of a clinician-rating instrument (HRSD). Results:We found that depressive symptoms assessed on the basis of HRSD, BDI-II, and PHQ-9 were equivalent in results, while the results obtained in HADS-D were significantly lower. Anxiety symptoms were found at approximate levels in HADS, SSAI, and GAD-7. The assessment of somatic symptoms in patients with CAD indicates that 87.5% of the subjects reported somatic symptoms of various intensity.Conclusions: Screening assessment of depression in patients with CAD gives different results depending on the tool used. We found that HADS significantly underestimates the percentage of patients with symptoms of depression in patients with CAD. Assessing anxiety symptoms with the aid of HADS gave outcomes close to the results gained by use of other tools.

show abstract

Section: Phq-15mentioning

confidence: 99%

Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Data included vital signs (i.e. blood pressure and body mass index), selected laboratory values (CD4 count, HIV viral load, lipids, blood glucose, and glycosylated hemoglobin), vaccinations received, and results from screenings routinely performed during CBOC visits [alcohol use by Alcohol Use Disorder Identification Test-Consumption (AUDIT-C) questions, 5 depression screening using the Patient Health Questionnaire, 6 and tobacco screening and cessation counseling].…”

Section: The Tcc Interventionmentioning

confidence: 99%

Mixed-Methods Evaluation of a Telehealth Collaborative Care Program for Persons with HIV Infection in a Rural Setting

et al. 2013

View full text Add to dashboard Cite

“…There are some other self-reported measures for depression screening, such as the Patient Health Questionnaire (PHQ-9) and Beck's Depression Inventory (BDI), which have been found to have a better overall diagnostic accuracy in patients with cardiometabolic disease (18,27,28).…”

Section: Strengths and Limitationsmentioning

confidence: 99%

“…Finally, the overall accuracy of depression screening in our study was reliant on HADS-D which is a self-reported measure and has various drawbacks when used for assessing depressive symptoms in patients with cardiometabolic disease in a primary care setting (18,27,28). There are some other self-reported measures for depression screening, such as the Patient Health Questionnaire (PHQ-9) and Beck's Depression Inventory (BDI), which have been found to have a better overall diagnostic accuracy in patients with cardiometabolic disease (18,27,28).…”

Section: Strengths and Limitationsmentioning

confidence: 99%

Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-up

Jani

Boachie

McCowan

et al. 2016

Eur Heart J Qual Care Clin Outcomes

View full text Add to dashboard Cite

Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies

Cited by 111 publications

References 159 publications

Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument

Depression and anxiety in patients with coronary artery disease, measured by means of self-report measures and clinician-rated instrument

Mixed-Methods Evaluation of a Telehealth Collaborative Care Program for Persons with HIV Infection in a Rural Setting

Relationship of depression screening in cardiometabolic disease with vascular events and mortality: findings from a large primary care cohort with 4 years follow-up

Contact Info

Product

Resources

About